4.6
Impact Factor
8.6
CiteScore
16 days
Time to First Decision

Anticancer Agents: Design, Synthesis and Evaluation II

This special issue belongs to the section “Medicinal Chemistry“.

Special Issue Information

Dear Colleagues,

The cancer-related mortality rate still remains high due to the various limitations of currently available therapies. The development of novel anticancer agents thus continues to be imperative to combat various deadly cancers. The emerging molecular targets and signal pathways enable the development of novel strategies to the rational design of new anticancer agents. Numerous well-established synthetic methods and biological screening assays pave the avenue for the discovery and development of new anticancer agents. The second edition of this Special Issue of Molecules continues to be devoted to all aspects of recent exploitation for new anticancer agents. Both original research and review articles, focusing on rational design, synthesis, and/or biological evaluation of various agents (including small molecules, natural products, endogenous molecules, antibodies and vaccines) as potential cancer therapeutics, are welcome to be submitted for publication in this Special Issue.

Dr. Qiao-Hong Chen
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

cancer drug discovery
cancer drug development
medicinal synthesis
cancer therapy
chemotherapeutics
anticancer activity
rational drug design
Structure-activity relationship
cancer therapeutics
anticancer agent
antitumor agent
biological evaluation
cancer bioassay
cancer screening assay
natural product
small molecule enzyme inhibitor
receptor antagonist
lead optimization
structure modification
structure manipulation
anti-proliferative activity
cytotoxicity
cell apoptosis
cancer cell models
anti-tumor efficacy

Benefits of Publishing in a Special Issue

Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Special Issue Policies